Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Tonix Pharmaceuticals (TNXP) has a market cap of $59.619 million USD. According to our data, Tonix Pharmaceuticals is ranked No.8051 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $59.62 M |
-3.33%
|
| Dec 31, 2024 | $61.68 M |
-97.42%
|
| Dec 29, 2023 | $2.39 B |
-83.59%
|
| Dec 30, 2022 | $14.58 B |
-96.61%
|
| Dec 31, 2021 | $430.60 B |
-47.06%
|
| Dec 31, 2020 | $813.36 B |
-41.88%
|
| Dec 31, 2019 | $1.399 T |
-94.68%
|
| Dec 31, 2018 | $26.315 T |
-93.62%
|
| Dec 29, 2017 | $412.662 T |
-26.60%
|
| Dec 30, 2016 | $562.177 T |
-93.87%
|
| Dec 31, 2015 | $9,174.253 T |
31.34%
|
| Dec 31, 2014 | $6,985.350 T |
-43.36%
|
| Dec 31, 2013 | $12,332.014 T |
-6.27%
|
| Dec 31, 2012 | $13,157.338 T |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Axsome Therapeutics
AXSM
|
$4.96 B |
0.000 M
|
USA
|
 Cassava Sciences
SAVA
|
$0.12 B |
0.000 M
|
USA
|
 Intra-Cellular Therapies
ITCI
|
$13.51 B |
-0.000 M
|
USA
|
 ACADIA Pharmaceuticals
ACAD
|
$2.96 B |
-0.000 M
|
USA
|
 Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
 Biohaven Pharmaceutical
BHVN
|
$4.10 B |
-0.000 M
|
USA
|
 Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
 Corcept Therapeutics
CORT
|
$6.18 B |
0.000 M
|
USA
|
 Minerva Neurosciences
NERV
|
$14.76 M |
0.000 M
|
USA
|
 Neurocrine Biosciences
NBIX
|
$14.86 B |
-0.000 M
|
USA
|
 Ovid Therapeutics
OVID
|
$49.92 M |
0.000 M
|
USA
|
 Anavex Life Sciences
AVXL
|
$0.85 B |
0.000 M
|
USA
|
| Market Cap | = | TNXP Stock Price | * | TNXP Shares Outstanding |
| = | $0.32 | * | 0.19 B | |
| = | $59.62 M |